Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Logo

David R Rahn & Associates Inc decreased its stake in Regeneron Pharmaceuticals (REGN) by 28.03% based on its latest 2018Q4 regulatory filing with the SEC. David R Rahn & Associates Inc sold 1,264 shares as the company’s stock rose 19.30% with the market. The institutional investor held 3,245 shares of the health care company at the end of 2018Q4, valued at $1.21M, down from 4,509 at the end of the previous reported quarter. David R Rahn & Associates Inc who had been investing in Regeneron Pharmaceuticals for a number of months, seems to be less bullish one the $34.15B market cap company. The stock decreased 3.49% or $11.31 during the last trading session, reaching $312.86. About 1.41 million shares traded or 81.66% up from the average. Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) has risen 34.82% since May 13, 2018 and is uptrending. It has outperformed by 30.45% the S&P500. Some Historical REGN News: 16/05/2018 – Positive Phase 3 Trial of DUPIXENT® (dupilumab) in Adolescents with lnadequately Controlled Moderate-to-severe Atopic Dermatitis; 15/05/2018 – Regeneron Presenting at Bank of America Conference Tomorrow; 21/05/2018 – Sanofi: New England Journal of Medicine publishes two positive Phase 3 trials showing Dupixent® (dupilumab) improved moderate-to-severe asthma; 23/04/2018 – Regeneron Announces Upcoming Investor Conference Presentations; 28/03/2018 – Regeneron CEO ‘optimistic’ will strike deals to lower $14,000 per-year cholesterol drug; 10/03/2018 – REGENERON, SANOFI STUDY OF PRALUENT PRESENTED AT ACC; 11/05/2018 – BAYER AG BAYGn.DE – EYLEA® GAINS APPROVAL IN CHINA FOR TREATMENT OF VISUAL IMPAIRMENT DUE TO NEOVASCULAR (WET) AGE-RELATED MACULAR DEGENERATION; 01/05/2018 – DEAL WITH REGENERON, SANOFI COMES AFTER DRUGMAKERS CUT PRICE; 03/04/2018 – REGENERON PHARMACEUTICALS INC REGN.O – EUROPEAN MEDICINES AGENCY (EMA) HAS ACCEPTED FOR REVIEW AN APPLICATION FOR DUPIXENT; 11/05/2018 – BAYER AG BAYGn.DE – BAYER RECEIVES APPROVAL FOR EYLEA® IN CHINA

Harvest Fund Advisors Llc decreased its stake in Eqm Midstream Partners Lp (EQM) by 1.37% based on its latest 2018Q4 regulatory filing with the SEC. Harvest Fund Advisors Llc sold 20,735 shares as the company’s stock declined 19.45% while stock markets rallied. The hedge fund held 1.50 million shares of the public utilities company at the end of 2018Q4, valued at $64.67 million, down from 1.52M at the end of the previous reported quarter. Harvest Fund Advisors Llc who had been investing in Eqm Midstream Partners Lp for a number of months, seems to be less bullish one the $8.93 billion market cap company. The stock increased 4.72% or $2.01 during the last trading session, reaching $44.55. About 536,268 shares traded. EQM Midstream Partners, LP (NYSE:EQM) has declined 36.97% since May 13, 2018 and is downtrending. It has underperformed by 41.34% the S&P500. Some Historical EQM News: 26/04/2018 – EQT Midstream Partners Sees 2019 Net $950M-Net $1.05B; 26/04/2018 – EQT Midstream Partners Enters Definitive Agreement With EQT GP Holdings to Acquire Olympus Gathering Syste; 26/04/2018 – EQT Midstream Partners Enters Into $2.5B 364-Day Syndicated Term Loan Facility; 26/04/2018 – EQT Midstream Partners, EQT GP Holdings and Rice Midstream Partners Announce Quarterly Distributions; 26/04/2018 – RMP May be Required to Reimburse EQM’s Expenses up to $5M or pay EQM $63.4M Termination Fee — Filin; 16/03/2018 – EQT Midstream Partners: FERC Policy to Disallow Income Tax Cost Recovery by Pipelines Owned by Master Limited Partnerships; 26/04/2018 – Merger of EQM and Rice Midstream Implies Transaction Value of $2.4B, Including Assumption of RMP Deb; 16/03/2018 – EQT MIDSTREAM SAYS EXPECTS NO IMPACT FROM FERC ANNOUNCEMENT; 19/04/2018 – DJ EQT Midstream Partners LP, Inst Holders, 1Q 2018 (EQM); 15/03/2018 – EQT CEO Resigns After One Year

More notable recent Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) news were published by: Nasdaq.com which released: “S&P 500 Movers: REGN, BR – Nasdaq” on March 13, 2019, also Nasdaq.com with their article: “Health Care Sector Update for 05/07/2019: CPRX,HSIC,REGN,SNY – Nasdaq” published on May 07, 2019, Nasdaq.com published: “Pre-Market Earnings Report for May 7, 2019 : AGN, EMR, REGN, SRE, TDG, RACE, CNHI, MYL, IT, BR, EXPD, MLCO – Nasdaq” on May 06, 2019. More interesting news about Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) were released by: Nasdaq.com and their article: “Noteworthy Thursday Option Activity: FLR, ALGN, REGN – Nasdaq” published on May 02, 2019 as well as Seekingalpha.com‘s news article titled: “Regeneron Pharmaceuticals misses by $1.07, misses on revenue – Seeking Alpha” with publication date: May 07, 2019.

Since December 12, 2018, it had 0 insider buys, and 4 insider sales for $55.44 million activity. Shares for $734,310 were sold by GOLDSTEIN JOSEPH L. VAGELOS P ROY sold $2,294 worth of stock or 6 shares. The insider Sanofi sold $54.04 million.

Investors sentiment decreased to 1.13 in Q4 2018. Its down 0.01, from 1.14 in 2018Q3. It fall, as 52 investors sold REGN shares while 165 reduced holdings. 72 funds opened positions while 174 raised stakes. 77.33 million shares or 9.82% more from 70.41 million shares in 2018Q3 were reported. Acadian Asset Management Ltd Co owns 23,614 shares for 0.04% of their portfolio. Prelude Capital Limited Company has 0.04% invested in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN). Private Advisor Ltd Llc accumulated 3,700 shares. Cleararc Cap Incorporated stated it has 0.15% in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN). Bb&T owns 18,608 shares. Sun Life Financial has 0.02% invested in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) for 214 shares. Focused Wealth Incorporated, a New York-based fund reported 9 shares. Everence Capital Management Inc invested in 0.15% or 1,737 shares. Ubs Asset Management Americas Incorporated accumulated 324,356 shares or 0% of the stock. Utah Retirement accumulated 14,774 shares or 0.12% of the stock. Tarbox Family Office Inc owns 21 shares. Armistice Limited Liability Corporation reported 70,000 shares or 1.98% of all its holdings. National Bank Of Nova Scotia has 0.03% invested in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) for 16,621 shares. Fdx Advisors Incorporated invested in 5,774 shares. M&T Commercial Bank reported 6,416 shares or 0.01% of all its holdings.

Harvest Fund Advisors Llc, which manages about $5.20B and $8.66B US Long portfolio, upped its stake in Cheniere Energy Inc (NYSEMKT:LNG) by 317,350 shares to 4.41M shares, valued at $261.21M in 2018Q4, according to the filing. It also increased its holding in Magellan Midstream Prtnrs Lp (NYSE:MMP) by 267,644 shares in the quarter, for a total of 7.56M shares, and has risen its stake in Genesis Energy Lp (NYSE:GEL).

More notable recent EQM Midstream Partners, LP (NYSE:EQM) news were published by: Fool.com which released: “Why EQGP Holdings Is Surging Today While EQM Midstream Is Slumping – Motley Fool” on November 30, 2018, also Seekingalpha.com with their article: “EQM Midstream Partners, LP 2019 Q1 – Results – Earnings Call Slides – Seeking Alpha” published on April 30, 2019, Finance.Yahoo.com published: “EQM Midstream Partners LP (EQM) Q1 2019 Earnings Call Transcript – Yahoo Finance” on April 30, 2019. More interesting news about EQM Midstream Partners, LP (NYSE:EQM) were released by: Fool.com and their article: “3 Ultra-High-Yield Dividend Stocks You Won’t Want to Miss – The Motley Fool” published on March 24, 2019 as well as Seekingalpha.com‘s news article titled: “EQM Midstream to buy stakes in Marcellus-Utica pipelines for $1B – Seeking Alpha” with publication date: March 14, 2019.

Investors sentiment decreased to 0.74 in 2018 Q4. Its down 1.14, from 1.88 in 2018Q3. It dropped, as 17 investors sold EQM shares while 61 reduced holdings. 25 funds opened positions while 33 raised stakes. 74.61 million shares or 2.26% less from 76.34 million shares in 2018Q3 were reported. Cohen & Steers, New York-based fund reported 302,498 shares. Rafferty Asset Management Ltd Llc accumulated 53,220 shares or 0.05% of the stock. Brookfield Asset Mngmt accumulated 2.18 million shares. Cushing Asset Management Lp holds 787,140 shares. Gsa Capital Partners Llp has invested 0.02% in EQM Midstream Partners, LP (NYSE:EQM). Diversified Co has invested 0.07% in EQM Midstream Partners, LP (NYSE:EQM). Invesco Limited invested 0% in EQM Midstream Partners, LP (NYSE:EQM). Virtu Financial Limited Liability Corporation owns 20,376 shares for 0.05% of their portfolio. Northwestern Mutual Wealth Management Communication, a Wisconsin-based fund reported 203 shares. Heronetta Limited Partnership holds 4.06% or 144,789 shares. Parallax Volatility Advisers LP has invested 0% of its portfolio in EQM Midstream Partners, LP (NYSE:EQM). Parkside Comml Bank And Tru owns 4,505 shares. Hsbc Hldg Pcl holds 0% of its portfolio in EQM Midstream Partners, LP (NYSE:EQM) for 31,726 shares. Kayne Anderson Cap Limited Partnership holds 1.32% of its portfolio in EQM Midstream Partners, LP (NYSE:EQM) for 1.97 million shares. Bessemer Gru holds 0% in EQM Midstream Partners, LP (NYSE:EQM) or 3,600 shares.

Analysts await EQM Midstream Partners, LP (NYSE:EQM) to report earnings on July, 25. They expect $1.01 EPS, down 7.34% or $0.08 from last year’s $1.09 per share. EQM’s profit will be $202.45 million for 11.03 P/E if the $1.01 EPS becomes a reality. After $1.56 actual EPS reported by EQM Midstream Partners, LP for the previous quarter, Wall Street now forecasts -35.26% negative EPS growth.

EQM Midstream Partners, LP (NYSE:EQM) Institutional Positions Chart

Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.



Source link

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *